1-Methyl-5-(tri-n-butylstannyl)imidazole → HCID 90411751, compound
Reaction equation
[NH2:1][C:2]1[C:11]([C:12]([NH:14][C:15]2[S:19][N:18]=[C:17]([CH3:20])[C:16]=2Br)=[O:13])=[C:5]2[N:6]=[CH:7][C:8]([F:10])=[CH:9][N:4]2[N:3]=1.C([Sn](CCCC)(CCCC)[C:27]1[N:28]([CH3:32])[CH:29]=[N:30][CH:31]=1)CCC>CN(C=O)C>[NH2:1][C:2]1[C:11]([C:12]([NH:14][C:15]2[S:19][N:18]=[C:17]([CH3:20])[C:16]=2[C:27]2[N:28]([CH3:32])[CH:29]=[N:30][CH:31]=2)=[O:13])=[C:5]2[N:6]=[CH:7][C:8]([F:10])=[CH:9][N:4]2[N:3]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 110 °C
Procedure
2-amino-N-(4-bromo-3-methyl-isothiazol-5-yl)-6-fluoro-pyrazolo[1,5-a]pyrimidine-3-carboxamide (20 mg, 0.05388 mmol), tributyl-(3-methylimidazol-4-yl)stannane (40.01 mg, 0.1078 mmol) dichloropalladium triphenylphosphane (7.566 mg, 0.01078 mmol) in DMF (2 mL) was degassed for 5 min, then heated at 110° C. After 2 h, the reaction mixture was loaded on a SCX column, washed with DCM/MeOH mixtures. The product was eluted with a 2M solution of ammonia in MeOH and the eluent was concentrated in vacuo. The residue was purified by fractionlynx to yield 2-amino-6-fluoro-N-(3-methyl-4-(1-methyl-1H-imidazol-5-yl)isothiazol-5-yl)pyrazolo[1,5-a]pyrimidine-3-carboxamide as a pale yellow solid. (8.09 mg, 37.4%). MS (ES+) 373.1.
Workup
- washwashed with DCM/MeOH mixtures
- washThe product was eluted with a 2M solution of ammonia in MeOH
- concentrationthe eluent was concentrated in vacuo
- customThe residue was purified by fractionlynx
Sources & evidence
- ORD record
- ord-33fa8d8599084a44b425a99e09700403
- Source dataset
- uspto-grants-2015_02
- Patent number
- US08957078B2
Reaction notes
Loading…